comparemela.com

Latest Breaking News On - Nigel yip - Page 8 : comparemela.com

acnnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from acnnewswire.com Daily Mail and Mail on Sunday newspapers.

United statesHynes convention centerNigel yipDmitry samarskyBunny leeAlexis feinbergSirnaomics ltdPresent latest developmentsBased liver targeting platformsSuzhou biobayTriggers composedOligonucleotide discoverySirnaomics chief technologySirnaomics chief technology officerFinancial officerAcn newswire

Sirnaomics to Present Latest Developments on its GalNAc-Based Liver-Targeting Platforms and GalAhead™ Programs at the TIDES USA 2022

/PRNewswire/ Sirnaomics Ltd. ("Sirnaomics", stock code: 2257.HK), a leading biopharmaceutical company in discovery and development of RNAi therapeutics,.

United statesHynes convention centerNigel yipDmitry samarskyBunny leeAlexis feinbergSirnaomics ltdTriggers composedOligonucleotide discoverySirnaomics chief technologySirnaomics chief technology officerFinancial officerSirnaomics ltd

Sirnaomics Doses First Subject in Phase I Clinical Trial of STP707 for the Treatment of Liver Fibrosis in Primary Sclerosing Cholangitis

/PRNewswire/ Sirnaomics Ltd. ("Sirnaomics," stock code: 2257.HK), a leading biopharmaceutical company in discovery and development of RNAi therapeutics,.

United statesNigel yipMark corbaeBunny leeMichael molyneauxPatrick luLysine coSirnaomics ltdPrnewswire sirnaomics ltdSirnaomics executive directorExecutive directorHistidine lysine co polymerChief medical officerFinancial officerMedia contactSirnaomics ltd

RNAimmune Secures $27 Million Series A Round of Financing for Development of mRNA Therapeutics and Vaccines

/PRNewswire/ RNAimmune, Inc. (the "Company" or "RNAimmune"), a biopharmaceutical company specializing in discovery and development of mRNA-based.

United statesDong shenRepublic of seychellesNigel yipLos angelesBunny leeAlexis feinbergPatrick luRnaimmune incUniversity of californiaDrug administrationSirnaomics ltdRiver limited smoothBoulder fundUniversity of houstonSmooth river limited

Sirnaomics to Present Latest Developments on its GalNAc-Based Liver-Targeting Platforms and Product Pipeline at the 2022 Oligonucleotide & Precision Therapeutics Congress

Sirnaomics CTO Dmitry Samarsky, PhD, to Also Present OPT Congress Opening Remarks GAITHERSBURG, Md. and SUZHOU, China, March 14, 2022 /PRNewwire/ Sirnaomics.

United statesNigel yipBunny leeDmitry samarskyAlexis feinbergPatrick luCompany galaheadSirnaomics ltdCongress openingRevere hotel boston commonCambridge healthtech instituteAlso presentPrecision therapeuticsSirnaomics chief technology officerTriggers composedSirnaomics chief technology

vimarsana © 2020. All Rights Reserved.